Aliasger K. Salem - Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear Cell Renal Cell Carcinoma

Share this story

NSF LogoThis material is based upon work supported by the National Science Foundation under Award No.2242763